LEXEO Therapeutics Announces Positive Clinical Trial Data in Alzheimer’s Disease
According to information from the National Institute of Health, one in nine elderly people in the U.S. will be affected by Alzheimer’s disease (AD). A recent article in the Globe Newswire…